loading
Pmv Pharmaceuticals Inc stock is traded at $1.48, with a volume of 221.78K. It is up +0.68% in the last 24 hours and up +16.54% over the past month. PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.47
Open:
$1.48
24h Volume:
221.78K
Relative Volume:
0.79
Market Cap:
$78.43M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.48
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-2.63%
1M Performance:
+16.54%
6M Performance:
+4.96%
1Y Performance:
-3.27%
1-Day Range:
Value
$1.465
$1.54
1-Week Range:
Value
$1.42
$1.60
52-Week Range:
Value
$0.81
$1.82

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
Name
Pmv Pharmaceuticals Inc
Name
Phone
(609) 642-6670
Name
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Name
Employee
47
Name
Twitter
Name
Next Earnings Date
2025-03-04
Name
Latest SEC Filings
Name
PMVP's Discussions on Twitter

Compare PMVP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
PMVP
Pmv Pharmaceuticals Inc
1.48 82.40M 0 -51.47M -47.50M -1.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-08-24 Upgrade Oppenheimer Perform → Outperform
May-13-24 Initiated Craig Hallum Buy
Apr-12-24 Initiated Jefferies Buy
Dec-27-23 Initiated Ladenburg Thalmann Buy
Mar-02-22 Upgrade Oppenheimer Perform → Outperform
Sep-22-21 Upgrade Goldman Neutral → Buy
Aug-19-21 Initiated Oppenheimer Perform
Aug-02-21 Initiated Guggenheim Buy
Jul-29-21 Initiated H.C. Wainwright Buy
Oct-20-20 Initiated BofA Securities Buy
Oct-20-20 Initiated Cowen Outperform
Oct-20-20 Initiated Evercore ISI Outperform
Oct-20-20 Initiated Goldman Neutral
View All

Pmv Pharmaceuticals Inc Stock (PMVP) Latest News

pulisher
Aug 20, 2025

Visual analytics tools that track PMV Pharmaceuticals Inc. performance2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

RSI and MACD Indicate Shift in PMV Pharmaceuticals Inc. Sentiment2025 Volatility Report & Risk Adjusted Buy and Sell Alerts - beatles.ru

Aug 20, 2025
pulisher
Aug 20, 2025

Multi asset correlation models including PMV Pharmaceuticals Inc.2025 Analyst Calls & Free Community Supported Trade Ideas - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Building trade automation scripts for PMV Pharmaceuticals Inc.2025 Fundamental Recap & Verified Short-Term Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

How to escape a deep drawdown in PMV Pharmaceuticals Inc.July 2025 Short Interest & Weekly Breakout Watchlists - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Is it time to cut losses on PMV Pharmaceuticals Inc.July 2025 Momentum & Weekly Breakout Stock Alerts - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

What MACD signals say about PMV Pharmaceuticals Inc.Earnings Overview Report & Safe Investment Capital Preservation Plans - Newser

Aug 20, 2025
pulisher
Aug 20, 2025

Can technical indicators confirm PMV Pharmaceuticals Inc.’s reversalQuarterly Profit Summary & Consistent Growth Equity Picks - Newser

Aug 20, 2025
pulisher
Aug 19, 2025

Risk vs reward if holding onto PMV Pharmaceuticals Inc.Trade Ideas & Detailed Earnings Play Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

How high can PMV Pharmaceuticals Inc. stock goQuarterly Profit Report & Daily Profit Focused Screening - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Should you wait for a breakout in PMV Pharmaceuticals Inc.Quarterly Investment Review & Safe Entry Trade Reports - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionQuarterly Profit Report & Advanced Swing Trade Entry Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Using data filters to optimize entry into PMV Pharmaceuticals Inc.Buy Signal & Low Risk High Reward Ideas - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

PMV Pharmaceuticals Inc. recovery potential after sell offWeekly Trend Recap & Real-Time Volume Spike Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Can you recover from losses in PMV Pharmaceuticals Inc.July 2025 Institutional & Safe Capital Investment Plans - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Price action breakdown for PMV Pharmaceuticals Inc.2025 Key Highlights & Weekly High Return Stock Opportunities - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Earnings visualization tools for PMV Pharmaceuticals Inc.2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

What MACD and RSI say about PMV Pharmaceuticals Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Is PMV Pharmaceuticals Inc. a candidate for recovery playEarnings Growth Report & Smart Investment Allocation Insights - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsEarnings Recap Report & Smart Money Movement Tracker - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Analyzing recovery setups for PMV Pharmaceuticals Inc. investorsJuly 2025 Short Interest & Expert Curated Trade Setup Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

PMV Pharmaceuticals Inc. Tests 50 Day MA After Sharp DeclineAnalyst Upgrade & Weekly Watchlist for Consistent Profits - kangso.co.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Top chart patterns to watch in PMV Pharmaceuticals Inc.July 2025 Review & Daily Chart Pattern Signals - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Should you hold or exit PMV Pharmaceuticals Inc. nowTrade Risk Summary & Weekly Top Gainers Trade List - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Is PMV Pharmaceuticals Inc. forming a reversal patternWeekly Risk Report & Advanced Swing Trade Entry Plans - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Technical signs of recovery in PMV Pharmaceuticals Inc.Portfolio Profit Report & High Yield Equity Trading Tips - Newser

Aug 15, 2025
pulisher
Aug 14, 2025

Is PMV Pharmaceuticals Inc. reversing from oversold territoryMarket Growth Review & Free Community Consensus Stock Picks - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Short Term Charts Align With Long Term Uptrend in PMV Pharmaceuticals Inc.July 2025 Trends & Proven Capital Preservation Tips - beatles.ru

Aug 13, 2025
pulisher
Aug 13, 2025

What analysts say about PMV Pharmaceuticals Inc. stock outlookQuarterly Market Review & Fast Gain Stock Trading Tips - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsAnalyst Upgrade & Weekly Watchlist of Top Performers - Newser

Aug 12, 2025

Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Jalota Deepika
Chief Development Officer
Jul 01 '25
Sale
1.06
33,065
35,198
89,959
Carulli Michael
Chief Financial Officer
Jul 01 '25
Sale
1.06
28,249
30,077
60,146
Mack David Henry
President and CEO
Jul 01 '25
Sale
1.06
58,411
62,179
536,133
Mack David Henry
President and CEO
Dec 03 '24
Option Exercise
0.53
91,750
48,628
534,210
Mack David Henry
President and CEO
Jan 03 '25
Option Exercise
0.53
17,709
9,386
551,919
Jalota Deepika
Chief Development Officer
Sep 11 '24
Sale
1.50
7,218
10,853
118,283
Carulli Michael
Chief Financial Officer
Sep 11 '24
Sale
1.50
2,891
4,347
88,395
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):